An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. . N Engl J Med 2020;382:586.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med 2020;382:586.
PMID: 32023396